Poor control and management of cardiovascular risk factors among Albanian diabetic adult patients☆
Abstract
Background
Cardiovascular and metabolic risk factors represent potential targets for intervention. A good metabolic control, associated with control of blood pressure and cholesterol levels is proven to reduce the risk of cardiovascular disease among individuals with diabetes mellitus.
Objectives
To examine 2004–2005 medical records of adults with previously diagnosed diabetes and to evaluate the fulfillment of diabetes guidelines treatment, for the metabolic control and management of cardiovascular risk factors.
Research, design and methods
We reviewed the data from the National Register of Diabetes (Tirana district), updated during this period. As guidelines we used the ADA 2006 Recommendations for metabolic control, HTA, lipid profile and aspirin therapy.
Results
We examined 7259 medical records. Only 14.58% of the patients had an HbA1c <7%. Central obesity was present in 39% of our patients. Overall, only 31.9% of our patients achieved the target for blood pressure (SBP
<
130
mmHg and DBP
<
80
mmHg). Two-third of our patients had total cholesterol >200
mg/dl. In total, only 5.5% of our patients attained recommended goals of cardiovascular risk factors for HbA1c, blood pressure and lipid profile.
Conclusions
The follow-up of diabetic patients during the transient period in Albania is marked by a deterioration of diabetes metabolic control and poor management of cardiovascular risk factors. Further public health efforts are needed for better control of these risk factors among adults with diagnosed diabetes.
Keywords: Diabetes, Cardiovascular risk factors, Metabolic control, Blood pressure, Lipid profile, Guideline
To access this article, please choose from the options below
☆ Part of this study has been accepted as poster presentation in 2nd International Congress on “Prediabetes” and the Metabolic Syndrome in Barcelona, 25–28 April 2007.
PII: S1751-9918(07)00045-9
doi:10.1016/j.pcd.2007.04.009
© 2007 Primary Care Diabetes Europe. Published by Elsevier Inc. All rights reserved.
